Hetrombopag Uses, Dosage, Side Effects and more
Hetrombopag is under investigation in clinical trial NCT03976882 (Hetrombopag for the Treatment of Chemotherapy-induced Thrombocytopenia in Subjects With Malignancy.).
| Trade Name | Hetrombopag |
| Generic | Hetrombopag |
| Type | |
| Formula | C25H22N4O5 |
| Weight | Average: 458.474 Monoisotopic: 458.159019824 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
